Impact of cardiopulmonary bypass and surgical complexity on plasma soluble urokinase-type plasminogen activator receptor levels after cardiac surgery

References

• Hote M. Cardiac surgery risk scoring systems: in quest for the best. Heart Asia. 2018;10(1):e011017.
   PubMed Web of Science ®Google Scholar
• Polineni S, Parker DM, Alam SS, et al. Predictive ability of novel cardiac biomarkers ST2, galectin-3, and NT-ProBNP before cardiac surgery. J Am Heart Assoc. 2018;7:14.
   Web of Science ®Google Scholar
• Brown JR, Jacobs JP, Alam SS, et al. Utility of biomarkers to improve prediction of readmission or mortality after cardiac surgery. Ann Thorac Surg. 2018;106(5):1294–1301.
   PubMed Web of Science ®Google Scholar
• Brunner N, Nielsen HJ, Hamers M, et al. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. APMIS. 1999;107(1):160–167.
   PubMed Web of Science ®Google Scholar
• Hayek SS, Sever S, Ko YA, et al. Soluble urokinase receptor and chronic kidney disease. N Engl J Med. 2015;373(20):1916–1925.
   PubMed Web of Science ®Google Scholar
• Donadello K, Scolletta S, Covajes C, et al. suPAR as a prognostic biomarker in sepsis. BMC Med. 2012;10:2.
   PubMed Web of Science ®Google Scholar
• Borne Y, Persson M, Melander O, et al. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation. Eur J Heart Fail. 2014;16(4):377–383.
   PubMed Web of Science ®Google Scholar
• Sidenius N, Sier CF, Ullum H, et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood. 2000;96(13):4091–4095.
   PubMed Web of Science ®Google Scholar
• Donadello K, Scolletta S, Taccone FS, et al. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients. J Crit Care. 2014;29(1):144–149.
   PubMed Web of Science ®Google Scholar
• Koch A, Voigt S, Kruschinski C, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011;15(1):R63.
   PubMed Web of Science ®Google Scholar
• Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232–244.
   PubMed Web of Science ®Google Scholar
• Arkader R, Troster EJ, Abellan DM, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004;18(2):160–165.
   PubMed Web of Science ®Google Scholar
• Pesonen E, Passov A, Salminen US, et al. Heparin binding protein in adult heart surgery. Ann Thorac Surg. 2019;107(4):1154–1159.
   PubMed Web of Science ®Google Scholar
• Kragsbjerg P, Holmberg H, Vikerfors T. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. Eur J Surg. 1995;161(1):17–22.
   PubMedGoogle Scholar
• Mossanen JC, Pracht J, Jansen TU, et al. Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery. Int J Mol Sci. 2017;18(8):1662.
   PubMed Web of Science ®Google Scholar
• Hodges GW, Bang CN, Eugen-Olsen J, et al. SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis. Open Heart. 2018;5(1):e000743.
   PubMed Web of Science ®Google Scholar
• Gozdzik W, Adamik B, Gozdzik A, et al. Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use. PLoS One. 2014;9(6):e98923.
   PubMed Web of Science ®Google Scholar
• Sterner N, Fisher J, Thelaus L, et al. The dynamics of heparin-binding protein in cardiothoracic surgery – a pilot study. J Cardiothorac Vasc Anesth. 2021;8: 2640–2650.
   PubMed Web of Science ®Google Scholar
• Stephens RW, Nielsen HJ, Christensen IJ, et al. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst. 1999;91(10):869–874.
   PubMedGoogle Scholar
• Biccard BM, Devereaux PJ, Rodseth RN. Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting. Anaesthesia. 2014;69(5):484–493.
   PubMed Web of Science ®Google Scholar
• Pliyev BK. Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87). Mol Cell Biochem. 2009;321(1–2):111–122.
   PubMed Web of Science ®Google Scholar
• Gussen H, Hohlstein P, Bartneck M, et al. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness. J Intensive Care. 2019;7:40.
   PubMed Web of Science ®Google Scholar
• Chores JB, Holt DW. Colloid oncotic pressure, monitoring its effects in cardiac surgery. J Extra Corpor Technol. 2017;494:249–256.
   Google Scholar
• Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg. 2003;76(3):784–791. Discussion 92.
   PubMed Web of Science ®Google Scholar
• Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605.
   PubMed Web of Science ®Google Scholar
• Maes T, Meuwissen A, Diltoer M, et al. Impact of maintenance, resuscitation and unintended fluid therapy on global fluid load after elective coronary artery bypass surgery. J Crit Care. 2019;49:129–135.
   PubMed Web of Science ®Google Scholar
• Rasmussen LJ, Ladelund S, Haupt TH, et al. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study. Emerg Med J. 2016;33(11):769–775.
   PubMed Web of Science ®Google Scholar
• Lyngbaek S, Marott JL, Møller DV, et al. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Am J Cardiol. 2012;110(12):1756–1763.
   PubMed Web of Science ®Google Scholar